Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $3.25, $0.07 better than the analyst estimate of $3.18. Revenue for the quarter came in at $6.51 billion versus the consensus estimate of $6.23 billion.

The company will provide 2019 financial guidance on its earnings conference call this morning at 8:30 a.m. Eastern time.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.